Skip to content

Local clinical trial for COVID-19 vaccine put on hold after AstraZeneca IDs issue in patient

The clinical trial for a Coronavirus vaccine, which was taking place locally, has been put on hold.

It was taking place at the University of Rochester Medical Center, and involved a vaccine produced by AstraZeneca. The company voluntarily paused the Phase 3 clinical trial of the vaccine due to a potentially unexplained illness in a single research participant in the U.K.

As of Thursday none of the local volunteers have experienced any unexpected or severe reactions.

The research and trial will continue after a review is concluded. The 16 people in the Rochester area who have enrolled in the study since last week were contacted directly and informed of the incident.